Study S000153

Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01890993
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 952
Start: 2013-08
Primary completion: 2014-06
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: DRUG:liraglutide
Results posted: FALSE
Secondary identifiers: OTHER:U1111-1142-2764; OTHER:ENCEPP/SDPP/8135

Registered primary outcomes

Change in HbA1c (glycosylated haemoglobin) [Baseline (anytime within 3 months before therapy initiation), month 12 (+/-2)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.